Bagley; Scott W.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Bagley; Scott W..The latest application filed is for "glp-1 receptor agonists and uses thereof".
- Bagley; Scott W. - Mystic CT
- Bagley; Scott W. - Stonington CT
- Bagley; Scott W. - Groton CT
| Patent | Date |
|---|---|
| GLP-1 Receptor Agonists and Uses Thereof App 20210332034 - Aspnes; Gary Erik ; et al. | 2021-10-28 |
| GLP-1 Receptor Agonists and Uses Thereof App 20210163455 - Aspnes; Gary Erik ; et al. | 2021-06-03 |
| GLP-1 receptor agonists and uses thereof Grant 10,934,279 - Aspnes , et al. March 2, 2 | 2021-03-02 |
| Glp-1 Receptor Agonists And Uses Thereof App 20210047298 - Aspnes; Gary Erik ; et al. | 2021-02-18 |
| GLP-1 receptor agonists and uses thereof Grant 10,851,081 - Aspnes , et al. December 1, 2 | 2020-12-01 |
| Glp-1 Receptor Agonists And Uses Thereof App 20200255406 - Kind Code | 2020-08-13 |
| GLP-1 receptor agonists and uses thereof Grant 10,683,281 - Aspnes , et al. | 2020-06-16 |
| GLP-1 receptor agonists and uses thereof Grant 10,676,465 - Aspnes , et al. | 2020-06-09 |
| GLP-1 receptor agonists and uses thereof Grant 10,669,259 - Aspnes , et al. | 2020-06-02 |
| GLP-1 Receptor Agonists and Uses Thereof App 20190382387 - Aspnes; Gary Erik ; et al. | 2019-12-19 |
| GLP-1 Receptor Agonists and Uses Thereof App 20190382388 - Aspnes; Gary Erik ; et al. | 2019-12-19 |
| GLP-1 Receptor Agonists and Uses Thereof App 20190382384 - Aspnes; Gary Erik ; et al. | 2019-12-19 |
| GLP-1 Receptor Agonists and Uses Thereof App 20190119255 - Aspnes; Gary Erik ; et al. | 2019-04-25 |
| GLP-1 receptor agonists and uses thereof Grant 10,208,019 - Aspnes , et al. Feb | 2019-02-19 |
| GLP-1 Agonists and Uses Thereof App 20180170908 - Aspnes; Gary Erik ; et al. | 2018-06-21 |
| N1/N2-lactam acetyl-CoA carboxylase inhibitors Grant 9,181,252 - Griffith , et al. November 10, 2 | 2015-11-10 |
| N1/n2-lactam Acetyl-coa Carboxylase Inhibitors App 20150152109 - Griffith; David A. ; et al. | 2015-06-04 |
| N1/N2-lactam acetyl-CoA carboxylase inhibitors Grant 8,993,586 - Griffith , et al. March 31, 2 | 2015-03-31 |
| N1/n2-lactam Acetyl-coa Carboxylase Inhibitors App 20150025098 - Griffith; David A. ; et al. | 2015-01-22 |
| N1/N2-lactam acetyl-CoA carboxylase inhibitors Grant 8,859,773 - Griffith , et al. October 14, 2 | 2014-10-14 |
| N1/n2-lactam Acetyl-coa Carboxylase Inhibitors App 20120108619 - Griffith; David A. ; et al. | 2012-05-03 |
| Ppar Activators App 20070191429 - Bagley; Scott W. ; et al. | 2007-08-16 |
| Piperidine compounds useful as PPAR activators Grant 7,199,243 - Bagley , et al. April 3, 2 | 2007-04-03 |
| PPAR activators App 20040157885 - Bagley, Scott W. ; et al. | 2004-08-12 |
| Phenoxyphenylacetic acid derivatives Grant 5,668,176 - Bagley , et al. September 16, 1 | 1997-09-16 |
| Biphenyl compounds useful or endothelin antagonists Grant 5,565,485 - Bagley , et al. October 15, 1 | 1996-10-15 |
| Six-membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives Grant 5,334,598 - Bagley , et al. August 2, 1 | 1994-08-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 